Log in or Sign up for Free to view tailored content for your specialty!
Genitourinary Cancer News
Experts in oncology help advise NASA on space radiation health standard for astronauts
A select group of people who spend their day jobs fighting cancer — as surgical oncologists, radiation epidemiologists, or working in radiobiology and bionanotechnology — had a unique opportunity to lend their expertise to NASA.
City of Hope to acquire Cancer Treatment Centers of America for $390 million
City of Hope announced Wednesday that it has entered a definitive agreement to acquire Cancer Treatment Centers of America.
Log in or Sign up for Free to view tailored content for your specialty!
Data ‘raised the red flag’ regarding COVID-19 pandemic’s impact on cancer diagnoses
Substantial reductions in procedures used to diagnose cancer and in new cancer diagnoses occurred across the U.S. because of the COVID-19 pandemic, according to a review of a large database of U.S. veterans published in Cancer.
Racial, ethnic minority populations underrepresented in precision oncology studies
Racial and ethnic minority populations remain underrepresented in many precision oncology trials relative to their cancer incidence in the U.S., according to study results published in JAMA Network Open.
Yoga improves quality of life, immune response in men with prostate cancer
Yoga therapy improved quality of life, immune responses and expression of inflammatory cytokines in men with newly diagnosed prostate cancer, according to results of a pilot randomized controlled trial.
Belzutifan active in von Hippel-Lindau disease-associated renal cell carcinoma
Belzutifan demonstrated clinical efficacy among patients with von Hippel-Lindau disease-associated renal cell carcinoma, according to results of a phase 2 study published in The New England Journal of Medicine.
Should G-CSF be used to boost the immune system in patients with cancer and sepsis?
In certain settings.
Early recognition, prevention strategies could reduce costly burden of sepsis in patients with cancer
Sepsis is a leading cause of preventable death across the globe, and patients with cancer have a 10 times higher likelihood of developing this life-threatening condition than those without cancer.
Despite progress, certain populations remain underrepresented in cancer clinical trials
Although cancer clinical trial participation has increased among Black and Hispanic individuals, these populations — along with women and older adults — remained underrepresented, according to a study published in Cancer.
Most therapies tested in phase 3 cancer trials fail to confer meaningful survival benefit
More than 80% of therapies tested in phase 3 oncology trials did not demonstrate clinically meaningful benefit in extending survival, according to results of a study published in JNCCN — Journal of the National Comprehensive Cancer Network.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read